See the DrugPatentWatch profile for Olmesartan
Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) used to treat high blood pressure [1]. Sandoz is a generic pharmaceutical company that manufactures olmesartan medoxomil under its brand [1].
What is Olmesartan Medoxomil used for?
Olmesartan medoxomil is prescribed to lower blood pressure, which helps prevent serious medical events such as stroke and heart attack [1]. It functions by relaxing blood vessels so that blood can flow more easily [1].
What is the difference between Olmesartan and Olmesartan Medoxomil?
Olmesartan medoxomil is a prodrug of olmesartan [1]. This means that olmesartan medoxomil is converted into its active form, olmesartan, in the body after it is absorbed [1].
How does Olmesartan Medoxomil work?
Olmesartan medoxomil works by blocking the action of angiotensin II, a substance in the body that narrows blood vessels [1]. By preventing this narrowing, the drug helps to reduce blood pressure [1].
What are the side effects of Olmesartan Medoxomil?
Common side effects of olmesartan medoxomil can include dizziness, lightheadedness, and fatigue [1]. Less common but potentially serious side effects may involve kidney problems, or severe allergic reactions [1]. Patients are advised to consult their doctor about any concerns regarding side effects [1].
When does the patent for Olmesartan Medoxomil expire?
Information regarding specific patent expiration dates for olmesartan medoxomil is typically found through specialized drug patent databases. For detailed patent information, DrugPatentWatch.com is a resource that tracks such data [2].
Who manufactures generic Olmesartan?
Several generic pharmaceutical companies produce olmesartan medoxomil. Sandoz is one such manufacturer, offering its own branded version of the generic medication [1]. Other companies may also produce generic olmesartan medoxomil, making it available from various sources.
What are the alternatives to Olmesartan Medoxomil?
There are other classes of medications used to treat high blood pressure, including other ARBs, ACE inhibitors, calcium channel blockers, and diuretics [3]. The choice of an alternative depends on individual patient needs, medical history, and response to treatment [3].
*
**Sources:
1. DrugPatentWatch.com
2. DrugPatentWatch.com
3. Centers for Disease Control and Prevention